(Q44230021)

1 December 2017

title

Histochemical examination of expression of ras p21 protein and R 1881-binding protein in human prostatic cancers (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

2 November 2022

H. Sumiya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699574

2 November 2022

M. Masai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699574

2 November 2022

S. Akimoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699574

2 November 2022

R. Yatani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699574

2 November 2022

J. Shimazaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699574

2 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1699574

2 November 2022

publication date

1 January 1990

1 reference

full work available at URL

1 December 2017

https://api.elsevier.com/content/article/PII:027753799090152J?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

https://api.elsevier.com/content/article/PII:027753799090152J?httpAccept=text/plain

2 November 2022

1 reference

Crossref

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

European Journal of Cancer

2 November 2022

published in

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

786-789

1 reference

Oncogenes: a review with relevance to cancers of the urogenital tract

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Androphilic protein studied histochemically in stage D2 prostatic cancer

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Classification of prostatic carcinomas

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

The relationship of clinical classification to ras p21 expression in human non-small cell lung cancer

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Expression of cellular oncogenes in human prostatic carcinoma cell lines

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Activated Ki-ras oncogene in human prostatic adenocarcinoma

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Expression of ras oncogene p21 in prostate cancer

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Expression of p21ras in fresh primary and metastatic human colorectal tumors

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Expression of p21 ras gene products in breast cancer relates to histological types and to receptor and nodal status

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Intranuclear androgen receptor deployment and protooncogene expression in human diseased prostate

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodents

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

Immunohistochemical localization of c-erbB-2 in human breast carcinomas

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90152-J

2 November 2022

Identifiers

1 reference

1 December 2017

1 reference